Paul gets triple-A rating on royalties fund
New York-based Paul Capital Partners has securitised most of the assets in a $300m drug-royalty fund.
New York-based Paul Capital Partners has securitised most of the assets in a $300m drug-royalty fund.
Copyright PEI Media
Not for publication, email or dissemination